What CLSA says on Sun Pharma, M&M; Credit Suisse on Bharat Forge
indiatimes.com
economics
2022-05-31 06:45:00

Getty ImagesCredit Suisse said there is an underappreciated strength in auto exports while suggesting Indian CV sales have gone through a deep and long downcycle. The brokerage has a target of Rs 903 on the stock.NEW DELHI: Credit Suisse finds Bharat Forge's valuations benign at 18 times FY24 earnings. CLSA maintained its 'buy' rating on , even as the Q4 margin was a miss due to higher OPEX. This brokerage also maintained its 'buy' stance on Mahindra & Mahindra (M&M) amid positive commentary on the outlook.
